Mederal Pharmaceuticals

Mumbai, India Founded: 2018 • Age: 8 yrs
Serves as an online supplier of medical instruments for healthcare organizations.

About Mederal Pharmaceuticals

Mederal Pharmaceuticals was a Healthcare company based in Mumbai (India) founded in 2018. It serves as an online supplier of medical instruments for healthcare organizations. It operates on a B2B model. Its Indian entity Mederal Pharmaceuticals Private Limited reported revenue of β‚Ή12.25 Cr. The company is recorded as dissolved. Its focus areas include Medical Devices, Medical Instruments and Online Distribution. Its competitors include Zoplar and Lifegaurd; 1 of its 2 listed competitors has raised funding.

Company details

Mederal Pharmaceuticals, established in 2018, excels in providing healthcare solutions, developing medical devices, medical instruments, and online distribution. Serves as an online supplier of medical instruments for healthcare organizations. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Key Metrics
  • Annual Revenue
    ₹12.25 Cr

    FY 2025 · +36% YoY

  • Net Profit
    ₹8.2 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹11.7 Lakh

    FY 2025 · 1% margin

Board of directors of Mederal Pharmaceuticals Private Limited (Mederal Pharmaceuticals)

Mederal Pharmaceuticals Private Limited is the primary company behind Mederal Pharmaceuticals. The board of Mederal Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Dhaval Dhirajlal Akbari, appointed in 2018. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Dhaval Dhirajlal Akbari
DIN 08117815
Director24 Apr 20188 yrs 6 moMederal Pharmaceuticals Private Limited
Nitinn Satyendra Gupta
DIN 06938425
Director24 Apr 20188 yrs 6 moMederal Pharmaceuticals Private Limited

Financials of Mederal Pharmaceuticals

Figures of Mederal Pharmaceuticals Private Limited, the primary company behind Mederal Pharmaceuticals, for FY 2025. Revenue was ₹12.25 Cr (+36% year on year). Net profit was ₹8.2 Lakh (1% margin). EBITDA was ₹11.7 Lakh (1% margin). Revenue has grown at a compounded annual rate of +65% over three years and +23% over five years.

  • ₹12.25 CrRevenue · FY 2025 · +36% YoY
  • ₹8.2 LakhNet profit · 1% margin
  • ₹11.7 LakhEBITDA · 1% margin
  • ₹10 LakhPaid-up capital
  • +65%Revenue CAGR, 3 years
  • +23%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mederal Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Mederal Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Mederal Pharmaceuticals

Mederal Pharmaceuticals has 2 listed competitors in our database, 1 of them funded. They include Zoplar and Lifegaurd.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
zoplar.com2022Gurugram, India$4.77M14
B2B medical supply platform that simplifies procurement for hospitals and clinics by offering a wide range of medical devices, equipment, and consumables
lifeguard-med.com2010Chandigarh, India
An online platform for healthcare products is provided by Lifegaurd.
Premium access

Detailed competitors of Mederal Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mederal Pharmaceuticals

Mederal Pharmaceuticals was founded in 2018.

Mederal Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

The primary company behind Mederal Pharmaceuticals, Mederal Pharmaceuticals Private Limited, reported revenue of β‚Ή12.25 Cr for FY 2025, up 36% year on year.

Mederal Pharmaceuticals, established in 2018, excels in providing healthcare solutions, developing medical devices, medical instruments, and online distribution. Serves as an online supplier of medical instruments for healthcare organizations. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Mederal Pharmaceuticals's top competitors include Zoplar and Lifegaurd.

Mederal Pharmaceuticals operates through Mederal Pharmaceuticals Private Limited.

The legal entities of Mederal Pharmaceuticals currently have 2 directors, including Dhaval Dhirajlal Akbari, Nitinn Satyendra Gupta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available